RELMADA THERAPEUTICS, INC. (RLMD) Insider Trading

Name: RELMADA THERAPEUTICS, INC. (RLMD) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 11, 2026): Maged Shenouda (Chief Financial Officer): Purchase of 120,200 shares, $504.8K.

Get alerted when insiders trade RLMD

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta